Erratum: Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy(J Clin Invest. (2017)127:6(2118–2132) DOI: 10.1172/JCI92001)

11Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Following an inquiry at the University of Liverpool, the Editorial Board was recently informed that the mass spectrometry data provided by Daniel J. Antoine is unreliable and likely to be fraudulent. Specifically, data relating to HMGB1 isoforms presented in Figures 1B, 2, 4A, and 5A and Supplemental Figure 3 are not reliable. Due to this finding, the JCI is retracting this article. No issues have been raised with regard to any of the other data in the paper. The corresponding author has stated that data presented in Figure 1A and data related to total HMGB1 blood levels measured by ELISA, which include that in Figure 1B, Figure 2, and Figure 4A as well as data reported in Figure 3 and Figure 4B, are reliable. The corresponding author has also stated that all supplemental figures, except those depicting HMGB1 isoforms, are reliable.

Cite

CITATION STYLE

APA

Walker, L. E., Frigerio, F., Ravizza, T., Ricci, E., Tse, K., Jenkins, R. E., … Pirmohamed, M. (2019, May 1). Erratum: Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy(J Clin Invest. (2017)127:6(2118–2132) DOI: 10.1172/JCI92001). Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI129285

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free